Perspective
Our work in Perspective
-
Follow the Money to Understand How Drug Profits Flow
Only by following the money will a clear understanding emerge of the economic forces roiling the industry and driving price increases.
Categorized in -
Treatment-Specific Payment Approaches: The Case Of Macular Degeneration
Treatment for neovascular or wet age-related macular degeneration (nAMD) is an area where a change in Medicare Part B payment specific to this procedure has far more potential for substantial reductions in spending.
Categorized in -
Repealing the Individual Mandate Would Do Substantial Harm
Advocates of repealing the mandate claim that its repeal would do no harm. However, this argument suffers from two serious flaws.
Categorized in -
Pharmaceutical Industry Profits and Research and Development
Paul Ginsburg and Richard Frank question the premise that more innovation is always a good thing.
Categorized in -
Tying Reimbursement to Outcomes Is an Ideal Strategy for PCSK9 Inhibitors
Daniel Blumenthal, Dana Goldman, and Anupam Jena discuss potential for outcomes based pricing strategies.
Categorized in -
How Health Care Providers Can Help End the Overprescription of Opioids
Battling the opioid epidemic requires flexible, carefully designed, and rapidly evaluated policies.
Categorized in -
States Have Already Tried Trump’s Healthcare Order. It Went Badly.
Like many appealing ideas, this one, proposed by Sen. Rand Paul (R-Ky.), has hidden land mines that are already well-mapped out based on previous failed attempts to enact them, even in Paul’s home state of Kentucky.
Categorized in -
Switch and Save on Medicare Part D
Simply switching prescription drug plans could save seniors and the government billions.
Categorized in -
The Long-Term Benefits of Quality Early Childcare for Disadvantaged Mothers and their Children
This post discusses research on the life-cycle consequences of comprehensive early childcare programs.
-
How will the Graham-Cassidy Proposal Affect the Number of People with Health Insurance Coverage?
Based on this analysis, we estimate that the Graham-Cassidy legislation would reduce the number of people with insurance coverage by around 21 million each year during the 2020 through 2026 period.
Categorized in